Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mwango Kashoki

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
JAMA|December 12, 2013
Drug postmarketing studiesMwango Kashoki, Cathryn Lee, John Jenkins
The New England Journal of Medicine|September 21, 2017
FDA Oversight of Postmarketing StudiesMwango Kashoki, Cathryn Lee, Peter Stein
JAMA Internal Medicine|May 16, 2017
Publication and Reporting of the Results of Postmarket Studies for Drugs Required by the US Food and Drug Administration, 2009 to 2013Marisa L Cruz, Jing Xu, Mwango Kashoki, et al.
Clinical Pharmacology and Therapeutics|July 16, 2019
A Comparison of EMA and FDA Decisions for New Drug Marketing Applications 2014-2016: Concordance, Discordance, and WhyMwango Kashoki, Zahra Hanaizi, Stella Yordanova, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
JAMA|December 12, 2013
Drug postmarketing studiesMwango Kashoki, Cathryn Lee, John Jenkins
The New England Journal of Medicine|September 21, 2017
FDA Oversight of Postmarketing StudiesMwango Kashoki, Cathryn Lee, Peter Stein
JAMA Internal Medicine|May 16, 2017
Publication and Reporting of the Results of Postmarket Studies for Drugs Required by the US Food and Drug Administration, 2009 to 2013Marisa L Cruz, Jing Xu, Mwango Kashoki, et al.
Clinical Pharmacology and Therapeutics|July 16, 2019
A Comparison of EMA and FDA Decisions for New Drug Marketing Applications 2014-2016: Concordance, Discordance, and WhyMwango Kashoki, Zahra Hanaizi, Stella Yordanova, et al.
Pageof 1